Clinical trials

  • MBF-362 for Primary dysmenorrhea
  • PLATELET CONCENTRATE for Diminished ovarian reserve
  • SPVN20 for End-stage rod-cone dystrophy | Hereditary retinal dystrophy
  • NAXITAMAB for Ewing's sarcoma
  • NVG-2089 for Immune thrombocytopenia (ITP) | Primary immune thrombocytopenia
  • EPLONTERSEN for Transthyretin-mediated amyloid cardiomyopathy (ATTR-CM)
  • TARLATAMAB for Neuroendocrine carcinoma of the digestive system | Neuroendocrine carcinoma of unknown primary origin
  • ALLOGENEIC WHARTON'S JELLY-DERIVED MESENCHYMAL STEM CELLS for Fibrotic interstitial lung disease | Idiopathic pulmonary fibrosis | Post-COVID-19 pulmonary fibrosis
  • Ustekinumab for Crohn's disease
  • ISATUXIMAB for Multiple myeloma | Plasma cell myeloma
  • levosimendan for Heart failure
  • DASATINIB for Amnestic mild cognitive impairment | Alzheimer's disease (early stage)